Eli Lilly and Company
LLY
$1,252.24+3.60%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$991.62B
EV/Sales
15.8
P/E ratio
42.0
FY2025 Revenue
$65.18B
EPS (TTM)
$29.79
Gross Margin (FY2025)
83.04%
Profit Margin (FY2025)
31.67%
Beta
N/A
Div yield
0.56%
Sector
Healthcare
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 42.0.
Use this LLY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LLY income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Eli Lilly and Company (LLY) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Eli Lilly and Company (LLY) revenue for Dec 31, 2025 was $65.18B. Net income was $20.64B. Statements: https://lician.com/financials/lly
Eli Lilly and Company (LLY) trailing P/E is 42.0 on the latest cached fundamentals snapshot.
Eli Lilly and Company (LLY) market capitalization is $991.62B on the latest cached snapshot.
Eli Lilly and Company (LLY) cached previous close $1,208.74; day range $1,235.04 – $1,252.24; volume 3,731,174. Session quote: https://lician.com/quote/lly
Eli Lilly and Company (LLY) latest cached earnings event is "LLY earnings" on Oct 29, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LLY filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/lly